Eversana, a pharmaceutical marketing company, and Waltz Health, a digital recipe drug company, are merging into an entity of $ 6 billion, announced on Tuesday.
Eversana, based in Chicago, serves more than 650 pharmaceutical and biotechnology companies and helps them take therapies to the market. Its services include the distribution of inventory and marketing and advertising to doctors. He also helped Eli Lilly with the creation of Lillydirect, a direct consumer platform that allows patients to access certain Eli Lilly drugs, including zero LPG-1.
Waltz Health, also based in Chicago, serves payers, employers and pharmacies. It has a platform called Waltz Connect, which coincides with patients with the most appropriate pharmacy for them when they are prescribed a special medicine. It also provides information from health plans about the member’s condition, prescription, pharmacy contact information and more.
The fusion will gather the capacities of the thesis companies under the name of Eversana. The terms of the agreement were not revealed.
The combined company will continue to sell Waltz Connect and building its pharmacy network. Eversana, meanwhile, will create a new model that directly connects to pharmaceutical companies with payers and patients, similar to Lillydirect. It will take that model to the payers and put it in financed benefits plans.
Companions aim to address the high cost of prescribed medications through merger, particularly special medications such as LPG-1 and oncological therapies. These come with extremely high list prices and have great attachments, said Mark Thierer, co -founder and CEO of Waltz Health.
“Our model is actually joining the payers with the pharmaceutical industry, and our hope is to create a business model with less abrasion, less speed blows to obtain therapies in patients,” Thier said. “We are creating a better member experience … we are running along with the current model. We do not seek to fly it or in any way disintermed it.”
Thierer will serve as the CEO of the combined company. Before Waltz Health, it was the CEO of Optumrx after the acquisition of Catamaran of $ 13 billion from UnitedHealth Group.
The former CEO of Eversana, Jim Lang, will be a member of the Board.
Thierer has also been the president of Eversana during the last eight years, which gave him a “front row” in the company.
“The notion of trying to unite the pharmaceutical companies with the payers is something that nobody had done, and that happened my leg with the time that could be a good option.
Photo: Stas_v, Getty Images